Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition

Kathleen E. Fenerty; Michelle Padget; Benjamin Wolfson; Sofia R. Gameiro; Zhen Su; John H. Lee; Shahrooz Rabizadeh; Patrick Soon-Shiong; James W. Hodge

doi:10.1186/s40425-018-0445-4

Citation Tools

This article has a correction. Please see:

Correction to: Immunotherapy Utilizing the Combination of Natural Killer– and Antibody Dependent Cellular Cytotoxicity (ADCC)–Mediating Agents with Poly (ADP-ribose) polymerase (PARP) Inhibition - December 01, 2019

PDF

XML

Research Article

Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Cite this article as:: Fenerty KE, Padget M, Wolfson B, et al

Immunotherapy utilizing the combination of natural killer– and antibody dependent cellular cytotoxicity (ADCC)–mediating agents with poly (ADP-ribose) polymerase (PARP) inhibition

Journal for ImmunoTherapy of Cancer 2018;6:133. doi: 10.1186/s40425-018-0445-4

Log in using your username and password

Main menu

Log in using your username and password

You are here

This article has a correction. Please see:

Download to a citation manager

Read the full text or download the PDF:

Log in using your username and password